{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:05:10Z","timestamp":1792677910898,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7279","license":[{"start":{"date-parts":[[2010,1,21]],"date-time":"2010-01-21T00:00:00Z","timestamp":1264032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2010,1,21]],"date-time":"2010-01-21T00:00:00Z","timestamp":1264032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2010,1,21]],"date-time":"2010-01-21T00:00:00Z","timestamp":1264032000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,1,21]],"date-time":"2010-01-21T00:00:00Z","timestamp":1264032000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2010,1,21]]},"DOI":"10.1038\/nature08667","type":"journal-article","created":{"date-parts":[[2010,1,19]],"date-time":"2010-01-19T08:43:18Z","timestamp":1263890598000},"page":"E3-E3","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":144,"title":["Essentiality of FASII pathway for Staphylococcus aureus"],"prefix":"10.1038","volume":"463","author":[{"given":"Wendy","family":"Balemans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nacer","family":"Lounis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Gilissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Guillemont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenny","family":"Simmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Andries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Koul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnature08667_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nature07772","volume":"458","author":"S Brinster","year":"2009","unstructured":"Brinster, S. et al. Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens. Nature 458, 83\u201386 (2009)","journal-title":"Nature"},{"key":"BFnature08667_CR2","doi-asserted-by":"publisher","first-page":"8033","DOI":"10.1128\/IAI.73.12.8033-8038.2005","volume":"73","author":"C Weidenmaier","year":"2005","unstructured":"Weidenmaier, C. et al. DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model. Infect. Immun. 73, 8033\u20138038 (2005)","journal-title":"Infect. Immun."},{"key":"BFnature08667_CR3","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1084\/jem.193.9.1067","volume":"193","author":"A Peschel","year":"2001","unstructured":"Peschel, A. et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l\u2013lysine. J. Exp. Med. 193, 1067\u20131076 (2001)","journal-title":"J. Exp. Med."},{"key":"BFnature08667_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrmicro840","volume":"2","author":"A Koul","year":"2004","unstructured":"Koul, A., Herget, T., Klebl, B. & Ullrich, A. Interplay between mycobacteria and host signalling pathways. Nature Rev. Microbiol. 2, 189\u2013202 (2004)","journal-title":"Nature Rev. Microbiol."},{"key":"BFnature08667_CR5","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.276.5313.718","volume":"276","author":"BB Finlay","year":"1997","unstructured":"Finlay, B. B. & Cossart, P. Exploitation of mammalian host cell functions by bacterial pathogens. Science 276, 718\u2013725 (1997)","journal-title":"Science"},{"key":"BFnature08667_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0378-1097(03)00931-5","volume":"231","author":"Y Ji","year":"2004","unstructured":"Ji, Y. et al. Validation of antibacterial mechanism of action using regulated antisense RNA expression in Staphylococcus aureus . FEMS Microbiol. Lett. 231, 177\u2013184 (2004)","journal-title":"FEMS Microbiol. Lett."},{"key":"BFnature08667_CR7","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1042\/bst0301050","volume":"30","author":"H Marrakchi","year":"2002","unstructured":"Marrakchi, H., Zhang, Y. M. & Rock, C. O. Mechanistic diversity and regulation of Type II fatty acid synthesis. Biochem. Soc. Trans. 30, 1050\u20131055 (2002)","journal-title":"Biochem. Soc. Trans."},{"key":"BFnature08667_CR8","doi-asserted-by":"publisher","first-page":"8139","DOI":"10.1128\/JB.01275-07","volume":"189","author":"S Altabe","year":"2007","unstructured":"Altabe, S., Lopez, P. & de Mendoza, D. Isolation and characterization of unsaturated fatty acid auxotrophs of Streptococcus pneumoniae and Streptococcus mutans . J. Bacteriol. 189, 8139\u20138144 (2007)","journal-title":"J. Bacteriol."},{"key":"BFnature08667_CR9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrmicro1839","volume":"6","author":"YM Zhang","year":"2008","unstructured":"Zhang, Y. M. & Rock, C. O. Membrane lipid homeostasis in bacteria. Nature Rev. Microbiol. 6, 222\u2013233 (2008)","journal-title":"Nature Rev. Microbiol."},{"key":"BFnature08667_CR10","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S0076-6879(81)72041-X","volume":"72","author":"S Omura","year":"1981","unstructured":"Omura, S. Cerulenin. Methods Enzymol. 72, 520\u2013532 (1981)","journal-title":"Methods Enzymol."},{"key":"BFnature08667_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0163-7827(01)00012-1","volume":"40","author":"RJ Heath","year":"2001","unstructured":"Heath, R. J., White, S. W. & Rock, C. O. Lipid biosynthesis as a target for antibacterial agents. Prog. Lipid Res. 40, 467\u2013497 (2001)","journal-title":"Prog. Lipid Res."},{"key":"BFnature08667_CR12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nature04784","volume":"441","author":"J Wang","year":"2006","unstructured":"Wang, J. et al. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 441, 358\u2013361 (2006)","journal-title":"Nature"},{"key":"BFnature08667_CR13","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1128\/AAC.01562-06","volume":"51","author":"JH Yum","year":"2007","unstructured":"Yum, J. H. et al. In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea. Antimicrob. Agents Chemother. 51, 2591\u20132593 (2007)","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnature08667_CR14","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1128\/AAC.46.10.3118-3124.2002","volume":"46","author":"DJ Payne","year":"2002","unstructured":"Payne, D. J. et al. Discovery of a novel and potent class of FabI-directed antibacterial agents. Antimicrob. Agents Chemother. 46, 3118\u20133124 (2002)","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnature08667_CR15","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nm1466","volume":"12","author":"C Vilcheze","year":"2006","unstructured":"Vilcheze, C. et al. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Nature Med. 12, 1027\u20131029 (2006)","journal-title":"Nature Med."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nature08667.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature08667","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature08667.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T17:51:11Z","timestamp":1743789071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature08667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,21]]},"references-count":15,"journal-issue":{"issue":"7279","published-print":{"date-parts":[[2010,1,21]]}},"alternative-id":["BFnature08667"],"URL":"https:\/\/doi.org\/10.1038\/nature08667","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1990956.1557054","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,21]]},"assertion":[{"value":"18 September 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Competing financial interests: all authors are members of an antimicrobial drug discovery group working for a pharmaceutical company.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}